Skip to main content
Pluri Inc. logo

Pluri Inc. — Investor Relations & Filings

Ticker · PLUR ISIN · US72942G2030 LEI · 529900OZKMF7JGZMYM81 TA Manufacturing
Open in API
Filings indexed 2,723 across all filing types
Latest filing 2026-04-24 Annual Report
Country US United States of America
Listing TA PLUR

About Pluri Inc.

https://pluri-biotech.com/

Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.

Recent filings

Filing Released Lang Actions
Other Report or Announcement
Annual Report Classification · 1% confidence The document is explicitly titled '2025 ANNUAL REPORT' and contains the standard SEC header 'FORM 10-K', which is the official annual report filing for U.S. public companies. It includes all required sections such as 'Business', 'Risk Factors', 'Management’s Discussion and Analysis', and 'Financial Statements'. It is not an announcement of a report, but the report itself. FY 2025
2026-04-24 English
Other Report or Announcement
Report Publication Announcement Classification · 1% confidence The document is a short notice filed via the Israel Securities Authority and Tel Aviv Stock Exchange stating “Attached hereto is a report on materials for the annual meeting – annual report as of 30.06.2025” with a PDF filename. It does not contain the full annual report content; rather it announces that the report is attached. Under the “menu vs meal” rule, this is an announcement of publication of a report, not the report itself.
2026-04-24 English
Immediate Report of Meeting
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled “SCHEDULE 14A” and is a Definitive Proxy Statement under Section 14(a) of the Securities Exchange Act, containing notice of the annual meeting of shareholders, proposals for director election and auditor ratification, and proxy voting instructions. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-24 English
Immediate Report of Meeting
Proxy Solicitation & Information Statement Classification · 1% confidence The document is an immediate report (MAGNA C460) from Pluri Inc. notifying the convening of the annual general meeting, detailing date, location, and full agenda items including election of directors and ratification of auditors, and references an attached Proxy Statement (DEF14A). This aligns with materials sent to shareholders to provide information and request votes. Therefore, it should be classified as a Proxy Solicitation & Information Statement (PSI).
2026-04-24 English
ARS - Pluri Inc. (0001158780) (Filer)
Annual Report
2026-04-23 English
DEF 14A - Pluri Inc. (0001158780) (Filer)
Proxy Solicitation & Information Statement
2026-04-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.